“This year’s World Health Assembly represents a pivotal moment to advance policy reforms to deliver a more fit-for-purpose, equitable research and development (R&D) ecosystem,” stated the Global Health Technologies Coalition. To accelerate global health innovation and deliver health for all, they recommend WHO member states “take collective action now to establish more inclusive, globally distributed R&D systems and approaches.” Other Alliance members also attending WHA76 include Baraka Impact Finance, Cross-Border Impact Ventures, Gilead Sciences, Global Health Council, Google, Living Goods, Meta, PATH, Pathfinder International, Pfizer, PSI, ReSurge International, and Viamo.
